Abstract:Online hemodiafiltration (online HDF) and acetate-free biofiltration (AFB) are 2 innovative renal replacement therapies. Convincing evidence has shown that both techniques are superior to conventional hemodialysis in many aspects. The aim of the present investigation was to compare online HDF and AFB in 12 stable maintenance hemodialysis patients in a prospective, randomized crossover trial. Twelve stable dialysis patients, age 49.7 +/- 11.3 years and on dialysis for 83.5 +/- 76.7 months, were treated prospectively and randomly by either AFB, predilution HDF (pre-HDF), or postdilution HDF (post-HDF) for a total of 36 weeks using exclusively F60S high-flux dialyzers. Routine blood biochemical tests, bone metabolism parameters, and clearance for both small and larger molecular weight substances were measured at defined intervals. During the trial period inter- and intradialysis symptoms, e.g., hypotensive episodes and intradialysis arterial blood gas analyses, were recorded. Both online HDF and AFB were well accepted by the overwhelming majority of patients and also by the dialysis staff. Pretreatment sodium, total and ionized calcium, chloride, bicarbonate, and urea did not differ within or between the 3 treatment groups. Potassium increased slightly in HDF patients while phosphate and beta(2)-microglobulin (beta(2)-M) decreased in all groups. After dialysis, AFB patients exhibited a significantly higher bicarbonate concentration and lower potassium level when identical potassium concentrations in dialysate were used. Patients receiving AFB manifested less intradialysis partial pressure. of oxygen drop and partial pressure of carbon dioxide rise than those on HDF treatments. HDF treatments could afford higher single-pool and double-pool Kt/V, higher effective urea and beta(2)M clearance, and lower total interdialysis symptom scores than the AFB treatment method. While bone metabolism parameters did not differ between the 3 dialysis modalities, some parameters such as deoxypyridinoline in HDF and osteocalcin, pyridinoline, and deoxypyridinoline in AFB deteriorated at the end of the crossover study. Aluminum concentration decreased progressively to about one-third of prestudy values at the end of the study with all 3 treatments. AFB was associated with a lower predialysis mean arterial pressure (MAP), a smaller drop in MAP during treatment, and similar hypotension episodes compared with the 2 HDF treatments. Albumin concentration showed a trend to decrease during the first 2 months of the trial period followed by a slight increase thereafter but still significantly lower than initial value at the end of crossover. Both online HDF and AFB share most of the features of optimal renal replacement therapy. Online HDF is superior to AFB in such aspects as increased delivered dialysis dose both for small and larger molecular weight toxins and less interdialysis symptoms. On the other hand, AFB is associated with a smaller effect on arterial blood gas values and improved intradialysis hemodynamic tolerance. Some dialysis-related symptoms and complications in the case of our AFB practice could be attributable, at least in part, to low dialysate calcium level.

Middle‐size Molecule Clearance As Measured by Β2‐microglobulin in High‐flux Versus Low‐flux Dialysis and Hemodiafiltration: A Prospective Randomized Controlled Trial

Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial

Combination of Maintenance Hemodialysis with Hemoperfusion: A Safe and Effective Model of Artificial Kidney

Removal of Middle Molecules and Dialytic Albumin Loss: A Cross-over Study of Medium Cutoff and High-Flux Membranes with Hemodialysis and Hemodiafiltration

High-flux Hemodialysis Efficiently Removes Β_2-Microglobin and Improves Inflammation Status in Maintain Hemodialysis Patients

Efficacy and Safety of Expanded Hemodialysis in Hemodialysis Patients: a Meta-Analysis and Systematic Review

High- versus low-flux hemodialysis in removing solutes

Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial

Expanded Hemodialysis Enhancement in Middle Molecule Clearance for Patients With Low Blood Flow Rates of Tunneled Dialysis Catheters

Primary Clinical Experience in High Risk Uremic Patients Converted from Conventional to Short Daily Hemodialysis

Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration

The clinical study on dialysis effect and nutritional status of different dialysis modes

Different Ways in Flux Hemodialysis Treatment of Uremic Patients Compared

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

High-risk end-stage renal disease patients converted from conventional to short daily haemodialysis.

Online hemodiafiltration versus acetate-free biofiltration: a prospective crossover study.

Impact of hemoperfusion combined with hemodialysis on left ventricular function in patients with maintenance hemodialysis

Comparison of filter life span and solute removal during continuous renal replacement therapy: convection versus diffusion - A randomized controlled trial

Change from conventional haemodiafiltration to on-line haemodiafiltration

Effects of Different Models of Blood Purification on Clinical Outcomes in Patients with End-Stage Renal Disease

The solutes removal capability in four different membrane dialyzers in hemodialysis maintenance patients